Association between the stages of cervical cancer and chromosome 1 aneusomy

Cancer Genetics and Cytogenetics

Volumn 159, Issue 1, 2005, Pages 44-47

  Cortés Gutiérrez, Elva I ^a,b   Dávila Rodríguez, Martha I ^a   Muraira Rodríguez, Marycarmen ^a   Said Fernández, Salvador ^c   Cerda Flores, Ricardo M ^a,b  

^a Administracion de Correos No 4   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RISK; CANCER STAGING; CELL COUNT; CELL HETEROGENEITY; CHROMOSOME 1; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MEXICO; MONOSOMY; NUMERICAL CHROMOSOME ABERRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TETRASOMY; TRISOMY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS;

EID: 18144378360     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.10.001     Document Type: Article

References (24)

1. Secretaria de Salud, Dirección General de Epidemiología Histopathological Registry of Malignant Neoplasms [In Spanish] SSA, Mexico 1996
2. Y.S. Fu, J.W. Reagan, and R.M. Richart Definition of precursors Gynecol Oncol 12 2 Pt 2 1981 S220 S231
3. M.R. Mullokandov, N.G. Kholodilov, N.B. Atkin, R.D. Burk, A.B. Johnson, and H.P. Klinger Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status Cancer Res 56 1996 197 205
4. S. Heim, G. Alimena, R. Billstrom, D. Diverio, U. Kristoffersson, N. Mandahl, M. Nanni, and F. Mitelman Tetraploid karyotype (92,XXYY) in two patients with acute lymphoblastic leukaemia Cancer Genet Cytogenet 29 1987 129 133
5. N. Atkin Cytogenetics of carcinoma of the cervix uteri: a review Cancer Genet Cytogenet 95 1997 33 39
6. P. Segers, S. Haesen, P. Castelain, J.J. Amy, P. De Sutter, P. Van Dam, and M. Kirsch-Volders Study of numerical aberrations of chromosome 1 by fluorescent in situ hybridization and DNA content by densitometric analysis on (pre)-malignant cervical lesions Histochem J 27 1995 24 34
7. P. Segers, S. Haesen, J.J. Amy, P. De Sutter, P. Van Dam, and M. Kirsch-Volders Detection of premalignant stages in cervical smears with a biotinylated probe for chromosome 1 Cancer Genet Cytogenet 75 1994 120 129
8. D. Kurtycz, M. Nunez, T. Arts, C. Bauman, C. Harris, S. Inhorn, and L. Meisner Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia Diagn Cytopathol 15 1996 46 51
9. C. Mian, D. Bancher, P. Kohlberger, C. Kainz, A. Haitel, K. Czerwenka, J. Stani, G. Breitenecker, and H. Wiener Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection Gynecol Oncol 75 1999 41 46
10. S.A. Southern, and C.S. Herrington Interphase karyotypic analysis of chromosomes 11, 17 and X in invasive squamous-cell carcinoma of the cervix: morphological correlation with HPV infection Int J Cancer 70 1997 502 507
11. H. Hariu, and M. Matsuta Cervical cytology by means of fluorescence in situ hybridization with a set of chromosome-specific DNA probes J Obstet Gynaecol Res 22 1996 163 170
12. H.F. Mark, D. Feldman, M. Samy, C. Sun, S. Das, S. Mark, and J. Lathrop Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization Exp Mol Pathol 66 1999 157 162
13. J. Bulten, P.J. Poddighe, J.C. Robben, J.H. Gemmink, P.C. de Wilde, and A.G. Hanselaar Interphase cytogenetic analysis of cervical intraepithelial neoplasia Am J Pathol 152 1998 495 503
14. H.F.L. Mark, R. Jenkins, and W.A. Miller Current applications of molecular cytogenetic technology Ann Clin Lab Sci 27 1997 47 56
15. W. Creasman New gynecologic cancer staging Obstet Gynecol 75 1990 287 288
16. D. Pinkel, J. Landegent, C. Collins, J. Fuscoe, R. Segraves, J. Lucas, and J. Gray Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4 Proc Natl Acad Sci U S A 85 1988 9138 9142
17. E.P.J. Arnoldus, I.A. Noordermeer, A.C.B. Peters, J.H.C. Voormolen, G.T.A.M. Bots, A.K. Raap, and M. van der Ploeg Interphase cytogenetics of brain tumors Genes Chromosomes Cancer 3 1991 101 107
18. W.L. Kuo, H. Tenjin, R. Segraves, D. Pinkel, M.S. Golbus, and J. Gray Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes Am J Hum Genet 49 1991 112 119
19. 2 and the problem of small samples Mol Biol Evol 6 1989 539 545
20. N.C. Popescu, D. Zimonjic, and J.A. DiPaolo Viral integration, fragile sites, and proto-oncogenes in human neoplasia Hum Genet 84 1990 383 386
21. T.H. Cheung, T.K. Chung, C.S. Poon, G.M. Hampton, V.W. Wang, and Y.F. Wong Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma Cancer 86 1999 1294 1298
22. P.H. Rao, H. Arias-Pulido, X.Y. Lu, C.P. Harris, H. Vargas, F.F. Zhang, G. Narayan, A. Schneider, M.B. Terry, and V.V.V.S. Murty Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma BMC Cancer 4 2004 5
23. K. Heselmeyer-Haddad, V. Janz, P.E. Castle, N. Chaudhri, N. White, K. Wilber, L.E. Morrison, G. Auer, F.H. Burroughs, M.E. Sherman, and T. Ried Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia Am J Pathol 163 2003 1405 1416
24. Y. Chen, R. Mosher, X. Zhao, J. Deeds, M. Morrissey, B. Bryant, D. Yang, D. Meyer, F. Cronin, B.S. Gostout, K. Smith-McCune, and R. Schlegel Identification of cervical cancer markers by cDNA and tissue microarrays Cancer Res 63 2003 1927 1935